Nov 28 2011
IrriMax Corporation announced today that Geo-Med, LLC (www.geomedsdvo.com), a Service-Disabled Veteran-Owned Small Business, will now be responsible for sales and distribution of the IrriSept® product line (www.irrisept.com) to U.S. government facilities and the military marketplace. The unique cleansing and debridement system is designed for use on a wide variety of wounds including surgical wounds, skin and soft tissue infections, abscesses, deep traumatic wounds, lacerations and puncture wounds. In their first joint effort, the two companies will introduce IrriSept to the military orthopedic community at the upcoming Society of Military Orthopedic Surgeons 53rd Annual Meeting, Dec. 13-15 in San Diego, Calif.
“We are excited to partner with Geo-Med which will provide the professional sales organization needed to expand IrriSept's distribution.”
"We are eager to offer Geo-Med's customers an alternative to saline irrigation with IrriSept, the first and only FDA-cleared cleansing and debridement system containing CHG," explains Gareth Clarke, chief executive officer of IrriMax. "We believe IrriSept has great potential in the military healthcare market.
"The 0.05 percent CHG concentration in IrriSept has been shown effective in laboratory testing against a variety of bacteria and fungi, including Staph and MRSA," continues Clarke. "We are excited to partner with Geo-Med which will provide the professional sales organization needed to expand IrriSept's distribution."
"We believe this new product will be of great value to our primary customer base: VA medical centers, military treatment facilities and Indian Health Services," said Mike Locke, CEO of Geo-Med. "IrriSept has the potential to improve patient outcomes, decrease hospital lengths of stay and help medical facilities address infection-related challenges."
Source:
IrriMax Corporation and Geo-Med